Table 4 The prevalence and number of conditions in the sample population
Condition | CWS | CWNS | ||||
|---|---|---|---|---|---|---|
Male (%) | Female (%) | Total (%) | Male (%) | Female (%) | Total (%) | |
ADHD/ADD | 520 (29.80) | 135 (18.72) | 655 (26.56) | 7420 (11.52) | 3203 (5.21) | 10,623 (8.43) |
Asthma | 221 (46.72) | 82 (45.30) | 303 (46.33) | 3869 (34.05) | 2964 (36.59) | 19,462 (35.11) |
Autism | 195 (11.17) | 61 (8.45) | 256 (10.38) | 1475 (2.29) | 409 (0.66) | 1884 (1.49) |
Other heart conditions | 50 (2.86) | 23 (3.18) | 73 (2.95) | 579 (0.90) | 537 (0.87) | 1116 (0.89) |
Cerebral palsy | 39 (2.23) | 23 (3.18) | 62 (2.51) | 367 (0.57) | 310 (0.50) | 677 (0.54) |
Downs Syndrome | 23 (1.31) | 8 (1.11) | 31 (1.25) | 86 (0.13) | 75 (0.12) | 161 (0.13) |
Congenital heart disease | 9 (0.51) | 6 (0.83) | 15 (0.61) | 127 (0.20) | 134 (0.22) | 261 (0.21) |
Diabetes | 8 (0.46) | 4 (0.55) | 12 (0.49) | 151 (0.23) | 158 (0.26) | 309 (0.25) |
Sickle cell anemia | 8 (0.46) | 2 (0.28) | 10 (0.40) | 92 (0.14) | 91 (0.15) | 183 (0.15) |
Arthritis | 6 (0.34) | 5 (0.69) | 11 (0.45) | 48 (0.074) | 91 (0.148) | 139 (0.110) |
Muscular dystrophy | 4 (0.23) | 4 (0.55) | 8 (0.32) | 21 (0.033) | 19 (0.031) | 40 (0.032) |
Cystic fibrosis | 0 | 0 | 0 | 24 (0.037) | 21 (0.034) | 45 (0.036) |